Myriad filed its brief with the Federal Circuit last Friday in its appeal of the district court decision in AMP v. PTO, which found Myriad's gene patents to be patent ineligible. The brief is available here, I will provide some commentary tomorrow.
Right here is the perfect website for everyone who wants to understand this topic. You understand a whole lot its almost tough to argue with you (not that I personally will need to…HaHa). You certainly put a new spin on a subject that has been discussed for decades. Great stuff, just wonderful
I am a law professor at the University of Missouri-Kansas City School of Law. My primary research interests lie at the intersection of biotechnology and intellectual property. This blog provides analysis and commentary on recent developments relevant to this area of the law.
2 comments:
Right here is the perfect website for everyone who wants to understand this topic. You understand a whole lot its almost tough to argue with you (not that I personally will need to…HaHa). You certainly put a new spin on a subject that has been discussed for decades. Great stuff, just wonderful
Bss commerce
I really love that
Post a Comment